Patents by Inventor Sharon X. Mu

Sharon X. Mu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
    Publication number: 20140273089
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The inventio further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: AMGEN, INC.
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey
  • Response Element Regions
    Publication number: 20110165580
    Abstract: Response element regions, DNA constructs comprising response element regions, host cells comprising response element regions, and methods of using response element regions are provided.
    Type: Application
    Filed: December 6, 2010
    Publication date: July 7, 2011
    Inventors: Christiaan J.M. Saris, Shamin Summer, Sharon X. Mu, Jill A. Crouse
  • Response element regions
    Patent number: 7892733
    Abstract: Response element regions, DNA constructs comprising response element regions, host cells comprising response element regions, and methods of using response element regions are provided.
    Type: Grant
    Filed: April 22, 2005
    Date of Patent: February 22, 2011
    Assignee: Amgen Inc.
    Inventors: Christiaan J. M. Saris, Shamin Summer, Sharon X. Mu, Jill A. Crouse
  • Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof
    Patent number: 7348162
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: March 25, 2008
    Assignee: Amgen Inc.
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey
  • Fibroblast growth factor receptor-like molecules and uses thereof
    Publication number: 20030087384
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Application
    Filed: August 28, 2002
    Publication date: May 8, 2003
    Applicant: Amgen Inc. A Corporation of the State of Delaware
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey
  • Interleukin-1 receptor antagonist-related molecules and uses thereof
    Publication number: 20030004106
    Abstract: The present invention provides novel Interleukin-1 Receptor Antagonist-Related (IL-1ra-R) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing IL-1ra-R polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IL-1ra-R polypeptides.
    Type: Application
    Filed: May 6, 2002
    Publication date: January 2, 2003
    Applicant: Amgen, Inc., A Corporation of the State of Delaware
    Inventors: Christiaan M. Saris, Jennifer Giles, Sharon X. Mu, Min Xia, Michael Brian Bass, Roger Craveiro
  • Fibroblast growth factor receptor-like molecules and uses thereof
    Publication number: 20020009776
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Application
    Filed: March 22, 2001
    Publication date: January 24, 2002
    Applicant: Amgen, Inc.
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey